Articles

Surge acted as a precursor for the RSV-marketed drug landscape in 2023, says GlobalData.

RSV Designations Reached All-Time High in 2022, Data Shows

Company to discuss acquisition and expansion of executive leadership.

New company to be publicly listed as Citius Oncology, Inc.

Parties will establish a Center of Excellence in CMIC’s NJ plant. 

Logistics provider announced new hub coming to Kristiansand in February 2024.

Investment offers opportunity to expand global footprint, company says. 

DataHorizzon Research anticipates an 18.1% CAGR through next decade.

Thousands of pharmacies will earn streamlined access to the OneScan Pharmacy Pro Platform, company says. 

Executive comes with over 20 years of experience in the industry. 

Partnership intends to indirectly boost patient medication adherence rates in the process.